1. Home
  2. AVO vs GERN Comparison

AVO vs GERN Comparison

Compare AVO & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$12.71

Market Cap

827.7M

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.35

Market Cap

753.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVO
GERN
Founded
1983
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.7M
753.3M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
AVO
GERN
Price
$12.71
$1.35
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$17.00
$3.00
AVG Volume (30 Days)
267.5K
6.9M
Earning Date
12-18-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
66.53
N/A
EPS
0.55
N/A
Revenue
$1,426,600,000.00
$183,403,000.00
Revenue This Year
$11.93
$147.34
Revenue Next Year
N/A
$39.11
P/E Ratio
$23.00
N/A
Revenue Growth
25.34
522.13
52 Week Low
$9.56
$1.04
52 Week High
$15.25
$4.01

Technical Indicators

Market Signals
Indicator
AVO
GERN
Relative Strength Index (RSI) 67.25 60.64
Support Level $11.88 $1.21
Resistance Level $12.15 $1.42
Average True Range (ATR) 0.25 0.07
MACD 0.09 0.02
Stochastic Oscillator 93.87 74.14

Price Performance

Historical Comparison
AVO
GERN

About AVO Mission Produce Inc.

Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: